Consequently, hyperglycemia affects the kidney which in turn results in more hyperglycemia until the kidney is damaged if not controlled in time
FDA Approves DECNUPAZTM (pivekimab sunirine-pvzy) for Treatment of Adult Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare and Aggressive Blood Cancer With Limited Treatment Options DECNUPAZ is the first and only antibody-drug conjugate (ADC) approved for blastic plasmacytoid dendritic cell neoplasm (BPDCN) that is initiated in an outpatient setting DECNUPAZ marks AbbVies first ADC approved for blood cancer NORTH CHICAGO, Ill., May 27, 2026 /PRNewswire/ Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks To view or add a comment, sign in We've achieved 82% stable disease per RECIST, with 9 of 11 evaluable patients achieving stable disease, including one patient maintaining stable disease for over 15 months and another for 12 months
In reality, the surge of interest in medications like Ozempic and Mounjaro has highlighted something Ive seen for years in my private nutritional therapy practice: for many, the struggle with binge eating and emotional eating is deeply physiological, yet has an element of imbalance in hunger and fullness signals
Responsible use is essential , which includes supervision by a knowledgeable practitioner
.png)
